primary progressive multiple sclerosis
Showing 1 - 25 of 32
Ocrelizumab on Cortical Lesion Accumulation in PPMS
Not yet recruiting
- Primary Progressive Multiple Sclerosis
- Ocrelizumab
- (no location specified)
Aug 2, 2023
Ocrelizumab on Choroid Plexus Changes in Patients With PPMS
Not yet recruiting
- Primary Progressive Multiple Sclerosis
- Ocrelizumab
-
Buffalo, New YorkBuffalo Neuroimaging Analysis Center
Jul 26, 2023
Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary-progressive Multiple Sclerosis Trial in Belgium (Metformin
Not yet recruiting
- Multiple Sclerosis
- +2 more
- Metformin Hydrochloride 850 mg Oral Tablet
- Placebo
-
Brugge, Belgium
- +4 more
May 30, 2023
Relapsing Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Worldwide (Ocrelizumab IV, Ocrelizumab SC,
Active, not recruiting
- Relapsing Multiple Sclerosis
- Primary Progressive Multiple Sclerosis
- Ocrelizumab IV
- +5 more
-
Tampa, Florida
- +46 more
Jan 13, 2023
Upper Extremity Function in Multiple Sclerosis Advanced
Active, not recruiting
- Multiple Sclerosis
- +7 more
-
Tampa, FloridaCarol and Frank Morsani Center for Advanced Healthcare
Nov 2, 2022
Primary Progressive Multiple Sclerosis Trial in Israel, Moldova, Republic of (GA Depot 40mg once monthly, GA Depot 25mg once
Recruiting
- Primary Progressive Multiple Sclerosis
- GA Depot 40mg once monthly
- GA Depot 25mg once monthly
-
Haifa, Israel
- +6 more
Oct 30, 2022
Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Australia, Canada, United States
Active, not recruiting
- Primary Progressive Multiple Sclerosis
- Secondary Progressive Multiple Sclerosis
- ATA188
- Placebo
-
La Jolla, California
- +33 more
Jul 21, 2022
Primary Progressive Multiple Sclerosis, Exercise, Cardiorespiratory Fitness Trial in Valens (HIIT, MCT)
Recruiting
- Primary Progressive Multiple Sclerosis
- +2 more
- HIIT
- MCT
-
Valens, Sankt Gallen, SwitzerlandKlinik Valens, Valens rehabilitation clinic
Jun 9, 2022
Gray Matter Demyelination in Primary Progressive MS at 7T
Recruiting
- Primary Progressive Multiple Sclerosis
-
Hvidovre, DenmarkDanish Research Centre for Magnetic Resonance
Jun 5, 2022
Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Los Angeles (Metformin 500 Mg Oral
Recruiting
- Secondary Progressive Multiple Sclerosis
- Primary Progressive Multiple Sclerosis
- Metformin 500 Mg Oral Tablet, up to 4 tablets a day
- Placebo oral tablet identical to metformin, up to 4 tablets a day
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
May 2, 2022
Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial
Recruiting
- Relapsing Remitting Multiple Sclerosis
- +2 more
- Rituximab
- +4 more
-
Glostrup, Copenhagen, Denmark
- +11 more
May 3, 2022
Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis Trial
Active, not recruiting
- Secondary Progressive Multiple Sclerosis
- +2 more
- ACTH
- Placebo
-
Minneapolis, Minnesota
- +2 more
Mar 29, 2022
Primary Progressive Multiple Sclerosis Trial in Worldwide (Placebo, Laquinimod)
Completed
- Primary Progressive Multiple Sclerosis
- Placebo
- Laquinimod
-
Phoenix, Arizona
- +98 more
Mar 9, 2022
Relapsing Remitting Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial
Recruiting
- Relapsing Remitting Multiple Sclerosis
- +2 more
- Ixazomib (NINLARO®) capsules / Matching placebo capsules
-
London, Greater London, United KingdomRoyal London Hospital, Barts Health NHS Foundation Trust
Feb 17, 2022
Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Multiple Sclerosis Trial (Intranasal Foralumab
Withdrawn
- Primary Progressive Multiple Sclerosis
- +2 more
- Intranasal Foralumab Solution
- Placebo
- (no location specified)
Feb 14, 2022
Primary Progressive Multiple Sclerosis Trial in Durham (DUOC-01)
Recruiting
- Primary Progressive Multiple Sclerosis
- DUOC-01
-
Durham, North CarolinaDuke University Medical Center
Jan 25, 2022
Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Relapsing Multiple Sclerosis Trial in Boston
Recruiting
- Primary Progressive Multiple Sclerosis
- +3 more
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 20, 2021
Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Dublin (Fampridine, Placebo)
Completed
- Secondary Progressive Multiple Sclerosis
- Primary Progressive Multiple Sclerosis
- Fampridine
- Placebo
-
Dublin, Dublin 4, Ireland
- +1 more
Jul 8, 2021
Primary Progressive Multiple Sclerosis the MURDOCK Study
Completed
- Primary Progressive Multiple Sclerosis
- generation of 'omic markers of disease progression
-
Concord, North Carolina
- +2 more
May 26, 2021
Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial run by the NIAID (Idebenone)
Completed
- Multiple Sclerosis
- Primary Progressive Multiple Sclerosis
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 27, 2021
Primary Progressive Multiple Sclerosis Trial in Copenhagen (Dimethyl fumarate, Placebo)
Completed
- Primary Progressive Multiple Sclerosis
- Dimethyl fumarate
- Placebo
-
Copenhagen, DenmarkDanish Multiple Sclerosis Center, Department of neurology
Dec 22, 2020
Multiple Sclerosis, Relapse, Primary Progressive Multiple Sclerosis Trial in Paris (Ocrelizumab)
Recruiting
- Multiple Sclerosis
- +2 more
-
Paris, FranceHôpital Saint-Antoine - Service de Neurologie
Jan 27, 2020
Primary Progressive Multiple Sclerosis, Hemiparesis Trial in Columbus (Gaming CI Therapy)
Completed
- Primary Progressive Multiple Sclerosis
- Hemiparesis
- Gaming CI Therapy
-
Columbus, OhioThe Ohio State University, 2154 Dodd Hall
Apr 16, 2019
Multiple Sclerosis, Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Portland (Alpha Lipoic
Completed
- Multiple Sclerosis
- +3 more
- Alpha Lipoic Acid
-
Portland, OregonOregon Health & Science University
Mar 20, 2019
Primary Progressive Multiple Sclerosis Trial run by the NIAID (Idebenone, )
Completed
- Primary Progressive Multiple Sclerosis
- Idebenone
- placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 6, 2019